CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

WellSpan Health

Benjamin Lego, Senior Director of Risk Management

Rethinking Healthcare Risk in an Age of Convergence

Benjamin Lego

Benjamin Lego

Clinical Development Champion

As a seasoned Risk Management and Governance Leader, Benjamin Lego has earned extensive experience in regulatory compliance and organizational oversight. He is known for his thought leadership on topics such as public health, project management and workplace trends, regularly sharing insights with a large professional network on LinkedIn. Lego holds a Certified in Public Health (CPH) credential, which he actively maintains, demonstrating his commitment to ongoing professional development and community health standards. His work history includes leadership roles where he drives governance excellence and fosters cross-functional collaboration across teams and organizational functions.


Through this article, Lego presents healthcare risk as a systems challenge driven by converging pressures rather than isolated threats. He underscores that safety, operational performance and financial stability are deeply linked and that proactive risk management depends on clear governance, actionable data and strong clinician partnership.


Emerging Healthcare Risks: Convergence Replaces Isolated Threats


Healthcare risk today is less about isolated threats and more about convergence. Workforce burnout, growing care complexity and rapid regulatory change are colliding at the same time organizations face cybersecurity threats, supply chain instability and sustained financial pressure. These risks do not exist in silos; they compound one another. The real challenge is building systems that remain reliable under stress while maintaining trust, transparency and consistent performance.


Balancing Safety and Performance: Prevention Aligns Cost and Care


Patient safety and operational performance rise or fall together. Organizations that invest in safety reduce waste, rework and preventable harm. The balance comes from focusing on high-risk, high-impact areas where improvement benefits both patients and operations. Clear governance, meaningful data and a strong Just Culture allow teams to surface risk early and address it before it becomes costly. When safety is built into daily work, it stops being a trade-off and becomes a performance advantage.


Clinical Risk and Data: Translating Metrics Into Clinical Action


Data is the engine of proactive risk management. When incident reports, claims data, regulatory findings and operational metrics are viewed together, patterns emerge early.


The goal is not more dashboards; it is better insight.


Data must be translated into clear priorities that frontline leaders can act on. Paired with clinical expertise, data helps organizations anticipate failure points, target interventions and measure whether changes are actually reducing risk.


Partnering With Frontline Clinicians: Presence, Trust and Early Involvement


Partnership starts with presence and trust. Risk teams must understand frontline realities and involve clinicians early in problem-solving.


Shifting the focus from individual blame to system design encourages openness and learning. When clinicians see risk management as a partner that removes barriers and improves workflows, engagement follows.


Closing the loop on reported concerns and consistently applying ‘Just Culture’ principle keeps that trust intact.


Lessons From Adverse Events: Beyond Individual Error


Lasting improvement comes from looking beyond individual mistakes.


Adverse events expose weaknesses in processes, communication, technology and culture.


High reliability organizations treat these events as learning opportunities, strengthening standardization, clarifying accountability and reinforcing teamwork. When lessons learned lead to practical change and are shared transparently, organizations do not just prevent recurrence; they become more resilient.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Life sciences organizations continue to operate in an environment where scientific complexity, regulatory demands and patient expectations intersect under constant pressure. This perspective offers industry professionals a lens into how leadership clarity and cross-disciplinary alignment can strengthen decision-making across the development and commercialization lifecycle.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/-benjamin-lego-nwid-3472.html